Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder

<b>Background:</b> The efficacy of naltrexone in the treatment of alcohol use disorder (AUD) has been associated with a set of variables not directly related with the expression of opioid receptors. All the variables have been found to be highly associated with AUD itself or more severe clinical lev...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	João M. Castaldelli-Maia, André Malbergier, Adriana B. P. de Oliveira, Ricardo A. Amaral, André B. Negrão, Priscila D. Gonçalves, Antonio Ventriglio, Domenico de Berardis, Juliana de Antonio, Isabela Firigato, Gilka J. F. Gattás, Fernanda de Toledo Gonçalves
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2021-10-01
Schriftenreihe:	Biomolecules
Schlagworte:	alcohol naltrexone genotyping <i>ADH1B</i> <i>ADH1C</i> <i>ALDH2</i>
Online-Zugang:	https://www.mdpi.com/2218-273X/11/10/1495
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!